Global private equity major KKR has allocated $150-200 million to acquire assets and expand medical devices manufacturer Healthium MedTech, as part of its ongoing efforts to deepen healthcare investments in India, Mint has reported. The firm is actively seeking scalable and profitable assets that can be integrated with Healthium, which it acquired last year for about ₹7,000 crore, under a bolt-on strategy. Capital and resources have already been set aside for this purpose. KKR, which acquired Healthium through its fourth Asian fund, also holds stakes in JB Chemicals and Pharmaceuticals Ltd, Baby Memorial Hospital, Max Healthcare Pvt Ltd, Healthcare Global Enterprises Ltd, and Gland Pharma Ltd.
Read the full article: KKR Deepens India Healthcare Push with $200M Healthium Medtech Plan //
Source: https://www.business-standard.com/finance/news/kkr-healthium-medtech-india-healthcare-investment-200mn-expansion-125110700668_1.html